With an all new workhorse design, only Philips OmniWire pressure guide wire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.2-4
New design from tip-to-tail to improve navigation in complex anatomy.
The embedded conductive ribbons eliminate the need for a hollow hypo tube therefore making a larger solid core possible similar to the design of a workhorse guide wire.
Traditional pressure wire
Omniwire with solid core
Workhorse guide wire*
*Proximal cross-sections. Not to scale, for illustration purposes only
*Proximal cross-sections. Not to scale, for illustration purposes only.
Nitinal distal core and integrated conductive bands
The Nitinol core is super elastic for durability and shape recovery. Useful for long multi-vessel procedures. Integrated conductive bands enable the back end to be a continuous piece with no joints, designed to reduce kinking, facilitate device loading, device delivery and easy reconnects.
iFR is the gold standard among resting indices backed by clinical outcomes that reduces patient discomfort, procedural time and cost.2,3,5 while providing advance guidance with co-registration for confidence in your treatment decisions.
iFR is validated in the largest physiology clinical outcomes studies with data from over 4500 patients. 2,3
iFR is recognized by all three key cardiovascular societies. It is the only resting index with a class IA recommendation by the ESC, designated as “definitely beneficial” by SCAI, and included in both the ACC AUC and NCDR.6-9
iFR is the leading hyperemia-free physiologic index for measuring pressure in diagnostic and interventional procedures. Only offered by Philips, iFR is an evidence-based methodology that improves outcomes, saves time, and reduces patient discomfort. 5,10,11 iFR Co-registration maps the physiologic measurements, directly onto the angiogram enabling more complete procedural guidance. • Mapping of physiologic pressure drops onto the angiogram to better discern focal, serial or diffuse disease • Precise lesion severity, location and length assessment • Make length measurements without a cumbersome pull back device • Physiologic impact of a virtual stent
Plan your procedure with physiologic guidance.
* Co-registration tools available within IntraSight 7 configuration via SyncVision
OmniWire's solid core is ideal for multi-vessel disease and complex cases
First impression of the OmniWire with Dr. Singh
OmniWire testimonials
OmniWire performs in complex lesions and anatomy with a lot of tortuosity
OmniWire shape recovery and flexibility
OmniWire on tortuous, calcified lesions in the LAD
OmniWire tip shaping
Patient undergoes an angiogram and a pressure wire assessment with a new wire
Designed to flex through tortuous anatomy
Indications for use: The OmniWire pressure guide wire is indicated for use to measure pressure in blood vessels, including both coronary and peripheral vessels, during diagnostic angiography and/or any interventional procedures. It can also be used to facilitate the placement of catheters as well as other interventional devices in coronary and peripheral vessels. Blood pressure measurements provide hemodynamic information for the diagnosis and treatment of blood vessel disease. The device is indicated for patients undergoing diagnostic angiography and/or percutaneous interventions in the coronary and peripheral vessels. iFR has been FDA cleared for ischemia testing using proven dichotomous cut-point, 0.89. Ordering information
Order number | Product name | Size | Tip shape | |
89185 | OmniWire pressure guide wire | 185 cm | Straight Tip | ![]() |
89185J | OmniWire pressure guide wire | 185 cm | J-Tip | ![]() |
#futureofIGT, #futureofCAD, #SolidCore #CoronaryIntervention How would you improve interventional procedures? What do you think about the new IntraSight platform? Are we on the right track?
Connect with us via #futureofIGT / #OmniWire
Media contacts: Fabienne van der Feer fabienne.van.der.feer@philips.com Phone: +31 622 698 001
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.
1. Data on file.: D000410086_A, D000485394_A 2. Davies JE, et al., Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834. 3. Gotberg M, et al., iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813-1823. 4. Comparisons to Verrata Plus. Data/report internally on file or internal company’s data on file. Verification Report, D000410086/A 5. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decisionmaking.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018 6. Patel M, et al., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients with Stable Ischemic Heart Disease. J Am Coll Cardiol. 2017 May 2;69(17):2212-2241. 7. ACC CathPCI Hospital Registry. www.ncdr.com/WebNCDR/cathpci/home/datacollection. 8. Lofti A, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions. Catheter Cardiovasc Interv. 2018;1–12. 9. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. 10. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017. 11. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017. 12. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
You are about to visit a Philips global content page
Continue